Home/Pipeline/Neurovascular Portfolio Development

Neurovascular Portfolio Development

Ischemic and Hemorrhagic Stroke

Ongoing Iteration & Clinical StudiesActive

Key Facts

Indication
Ischemic and Hemorrhagic Stroke
Phase
Ongoing Iteration & Clinical Studies
Status
Active
Company

About BALT

Balt is a global, private leader in the neurovascular medical device sector with over 45 years of history. It boasts the world's broadest portfolio of devices for stroke treatment and is leveraging its core expertise to enter the peripheral vascular market. The company has experienced significant growth since 2015, now employing over 1,000 people across 16 global sites. Its mission centers on close collaboration with physicians to develop clinically relevant solutions for high unmet medical needs.

View full company profile